ImmuCell Corporation
ICCC
ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronaā¦ read more
Healthcare
Biotechnology
38 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$6.57
Price+5.29%
$0.33
1Y
Price
Market Cap
$59.431m
Small
Price/Earnings 3y Avg5y Avg
23.5x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+9.9%
EBITDA Margin-2.5%
Net Profit Margin+26.3%
Free Cash Flow Margin+9.9%
EBITDA Margin-2.5%
Net Profit Margin+26.3%
Free Cash Flow MarginRevenue
$27.769m
+4.8%
1y CAGR+16.9%
3y CAGR+11.8%
5y CAGREarnings
$2.324m
+207.8%
1y CAGR+46.3%
3y CAGR-736.7%
5y CAGREPS
$0.25
+196.2%
1y CAGR+42.4%
3y CAGR-743.2%
5y CAGRBook Value
$29.801m
$45.730m
Assets$15.929m
Liabilities$13.606m
DebtDebt to Assets
29.8%
2.5x
Debt to EBITDAFree Cash Flow
$1.764m
+1736.2%
1y CAGR+605.2%
3y CAGR+395.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company